Ikarian Capital’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-591,676
| Closed | -$191K | – | 104 |
|
|
2023
Q3 | $191K | Sell |
591,676
-300,000
| -34% | -$97K | 0.02% | 67 |
|
|
2023
Q2 | $300K | Buy |
+891,676
| New | +$300K | 0.05% | 66 |
|
|
2022
Q3 | – | Sell |
-615,856
| Closed | -$199K | – | 101 |
|
|
2022
Q2 | $199K | Sell |
615,856
-300,000
| -33% | -$96.9K | 0.04% | 81 |
|
|
2022
Q1 | $318K | Buy |
915,856
+62,176
| +7% | +$21.6K | 0.04% | 115 |
|
|
2021
Q4 | $307K | Sell |
853,680
-50,000
| -6% | -$18K | 0.05% | 117 |
|
|
2021
Q3 | $322K | Sell |
903,680
-40,628
| -4% | -$14.5K | 0.02% | 132 |
|
|
2021
Q2 | $346K | Sell |
944,308
-202,000
| -18% | -$74K | 0.03% | 140 |
|
|
2021
Q1 | $419K | Hold |
1,146,308
| – | – | 0.01% | 149 |
|
|
2020
Q4 | $416K | Sell |
1,146,308
-50,000
| -4% | -$18.1K | 0.02% | 106 |
|
|
2020
Q3 | $688K | Buy |
+1,196,308
| New | +$688K | 0.05% | 76 |
|